Soares, R. B., Gabr, J. B., Ash, M., Hosler, G., & Koarada, S. (2025). Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome. Case Reports in Rheumatology, 2025, 1. https://doi.org/10.1155/crrh/5560523
Chicago Style (17th ed.) CitationSoares, Ryan Bonaventure, Jihad Ben Gabr, Mark Ash, Gregory Hosler, and Syuichi Koarada. "Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome." Case Reports in Rheumatology 2025 (2025): 1. https://doi.org/10.1155/crrh/5560523.
MLA (9th ed.) CitationSoares, Ryan Bonaventure, et al. "Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome." Case Reports in Rheumatology, vol. 2025, 2025, p. 1, https://doi.org/10.1155/crrh/5560523.
Warning: These citations may not always be 100% accurate.